Richard Croarkin - 22 Jun 2022 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
22 Jun 2022
Transactions value $
$0
Form type
4
Filing time
24 Jun 2022, 16:24:51 UTC
Previous filing
13 Jun 2022
Next filing
21 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Award $0 +30,000 $0 30,000 22 Jun 2022 Common Stock 30,000 $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2023.